Skip to main content

Supernus Pharmaceuticals, Inc.

SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001356576

No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Supernus Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Supernus Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Supernus Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Khattar Jack A.President, CEO1,258,351Aug 14, 202612
Rubin JonathanSVP, Chief Medical Officer13,979Aug 14, 20265
Bhatt Padmanabh P.Sr. VP of IP, CSO18,637Aug 14, 20268
Mottola FrankSVP, Chief Tech. Ops. Officer19,544Aug 14, 20268
Dec Timothy CSenior Vice-President & CFO9,129Aug 14, 20267
Hudson Frederick M.Director60,413Mar 16, 20264
Horich William ToddSVP, Commercial Operations0Mar 10, 20261
Gemayel GeorgesDirector27,277Mar 9, 20263
Newhall Charles W IIIDirector124,119Feb 25, 20264
Barlow CarroleeDirector27,045Feb 25, 20262
Sensenig BethanyDirector0Feb 23, 20262
Siebert John MDirector87,943Feb 27, 20240
Martin Tami TillotsonSr. V.P., Regulatory Affairs86,933Feb 27, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2022 (view filing)Aug 41 dayMartin Tami TillotsonSr. V.P., Regulatory AffairsSSale−5.00K$32.98−$164.9K−5.4%87.2K after
Aug 9, 2022 (view filing)Aug 81 dayKhattar Jack A.President, CEOSSale−117.9K$31.46−$3.71M−14.4%701.3K after2 lots
Aug 10, 2022 (view filing)Aug 91 dayKhattar Jack A.President, CEOSSale−39.4K$31.15−$1.23M−5.2%725.0K after
Aug 11, 2022 (view filing)Aug 101 dayKhattar Jack A.President, CEOSSale−28.4K$31.22−$887.8K−3.7%741.4K after
Aug 17, 2022 (view filing)Aug 152 daysKhattar Jack A.President, CEOSSale−17.3K$34.03−$588.8K−2.2%759.9K after
Aug 18, 2022 (view filing)Aug 162 daysKhattar Jack A.President, CEOSSale−14.7K$34.01−$499.6K−1.9%775.6K after
Aug 23, 2022 (view filing)Aug 221 dayMartin Tami TillotsonSr. V.P., Regulatory AffairsSSale−5.00K$35.98−$179.9K−5.4%87.2K after
Nov 14, 2022 (view filing)Nov 95 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−700$34.97−$24.5K−29.9%1.64K after
Nov 15, 2022 (view filing)Nov 114 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−6.80K$34.95−$237.7K−80.5%1.64K after
Nov 17, 2022 (view filing)Nov 152 daysKhattar Jack A.President, CEOSSale−1.11K$35.00−$39.0K−0.1%780.7K after
Nov 22, 2022 (view filing)Nov 211 dayKhattar Jack A.President, CEOSSale−531$35.01−$18.6K−0.1%781.1K after
Nov 23, 2022 (view filing)Nov 221 dayKhattar Jack A.President, CEOSSale−600$35.00−$21.0K−0.1%781.4K after
Nov 28, 2022 (view filing)Nov 23-255 daysKhattar Jack A.President, CEOSSale−13.4K$35.16−$470.9K−1.7%789.4K after2 lots
Dec 2, 2022 (view filing)Dec 11 dayBhatt Padmanabh P.Sr. VP of IP, CSOSSale−5.00K$37.48−$187.4K−75.3%1.64K after
Dec 22, 2022 (view filing)Dec 20-212 daysKhattar Jack A.President, CEOSSale−15.4K$38.11−$585.3K−1.9%814.7K after2 lots
Jan 9, 2023 (view filing)Jan 63 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−174$39.90−$6.94K−9.6%1.64K after
Jan 19, 2023 (view filing)Jan 172 daysKhattar Jack A.President, CEOSSale−25.4K$40.03−$1.02M−3.1%791.2K after
Jan 19, 2023 (view filing)Jan 172 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−4.83K$39.92−$192.7K−74.6%1.64K after
Jan 20, 2023 (view filing)Jan 182 daysKhattar Jack A.President, CEOSSale−4.94K$40.40−$199.4K−0.6%794.3K after
Feb 2, 2023 (view filing)Jan 312 daysKhattar Jack A.President, CEOSSale−976$42.01−$41.0K−0.1%795.0K after
Feb 3, 2023 (view filing)Feb 12 daysKhattar Jack A.President, CEOSSale−300$42.01−$12.6K0.0%795.2K after
Feb 6, 2023 (view filing)Feb 24 daysKhattar Jack A.President, CEOSSale−13.5K$42.06−$569.2K−1.7%804.1K after
Feb 6, 2023 (view filing)Feb 33 daysKhattar Jack A.President, CEOSSale+200$42.02+$8.40K0.0%804.3K after
Mar 16, 2023 (view filing)Mar 142 daysMottola FrankSr VP, Quality, GMP Oper. & ITSSale−4.78K$35.99−$172.0K−50.2%4.74K after
Aug 29, 2023 (view filing)Aug 254 daysMartin Tami TillotsonSr. V.P., Regulatory AffairsSSale−5.13K$31.59−$162.2K−5.7%85.2K after
Sep 1, 2023 (view filing)Aug 302 daysMartin Tami TillotsonSr. V.P., Regulatory AffairsSSale−8.10K$32.00−$259.2K−8.7%85.2K after
Nov 16, 2023 (view filing)Nov 142 daysMottola FrankSVP, Quality, GMP, Ops, ITSSale−1.11K$28.13−$31.2K−16.3%5.68K after
Nov 17, 2023 (view filing)Nov 152 daysHudson Frederick M.DirectorSSale−9.09K$28.50−$259.2K−21.5%33.2K after2 lots
Nov 20, 2023 (view filing)Nov 164 daysNewhall Charles W IIIDirectorSSale−2.50K$28.01−$70.0K−2.1%117.1K after
Jan 12, 2024 (view filing)Jan 102 daysMartin Tami TillotsonSr. V.P., Regulatory AffairsSSale−8.00K$27.91−$223.3K−8.5%85.7K after10b5-1
Feb 28, 2024 (view filing)Feb 262 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−5.00K$30.21−$151.1K−36.8%8.57K after10b5-1
Mar 14, 2024 (view filing)Mar 122 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−3.88K$32.99−$128.1K−31.2%8.57K after10b5-1
Mar 15, 2024 (view filing)Mar 132 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−62.4K$33.74−$2.10M−87.9%8.57K after2 lots10b5-1
Mar 21, 2024 (view filing)Mar 192 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−12.4K$35.31−$436.6K−59.1%8.57K after10b5-1
Mar 22, 2024 (view filing)Mar 202 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−400$35.31−$14.1K−4.5%8.57K after10b5-1
Mar 25, 2024 (view filing)Mar 214 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−14.5K$35.31−$511.7K−62.8%8.57K after10b5-1
Sep 17, 2024 (view filing)Sep 134 daysGemayel GeorgesDirectorSSale−13.9K$31.33−$435.0K−51.0%13.3K after2 lots
Nov 8, 2024 (view filing)Nov 71 dayKhattar Jack A.President, CEOSSale−125.0K$36.68−$4.58M−11.9%926.2K after
Nov 8, 2024 (view filing)Nov 71 dayGemayel GeorgesDirectorSSale−14.2K$36.62−$520.5K−51.6%13.3K after
Nov 8, 2024 (view filing)Nov 71 dayMottola FrankSVP, Quality, GMP, Ops, ITSSale−15.0K$36.98−$554.7K−64.7%8.20K after
Nov 12, 2024 (view filing)Nov 84 daysKhattar Jack A.President, CEOSSale−125.0K$36.29−$4.54M−11.9%926.2K after
Nov 12, 2024 (view filing)Nov 84 daysGemayel GeorgesDirectorSSale−10.8K$36.30−$391.6K−44.8%13.3K after
Nov 12, 2024 (view filing)Nov 84 daysHudson Frederick M.DirectorSSale−8.72K$36.28−$316.4K−23.5%28.4K after
Nov 12, 2024 (view filing)Nov 111 dayNewhall Charles W IIIDirectorSSale−10.7K$36.24−$387.8K−7.6%130.3K after
Dec 4, 2024 (view filing)Dec 31 dayBhatt Padmanabh P.Sr. VP of IP, CSOSSale−21.5K$36.68−$788.4K−69.0%9.68K after2 lots10b5-1
Jan 29, 2025 (view filing)Jan 27-282 daysBhatt Padmanabh P.Sr. VP of IP, CSOSSale−3.27K$39.62−$129.7K−24.4%10.1K afterFrom original2 lots
Feb 5, 2025 (view filing)Feb 41 dayBhatt Padmanabh P.Sr. VP of IP, CSOSSale−9.48K$39.70−$376.2K−48.3%10.1K after10b5-1
Feb 24, 2025 (view filing)Feb 213 daysRubin JonathanSVP, Chief Medical OfficerSSale−927$39.15−$36.3K−10.6%7.85K after
Aug 8, 2025 (view filing)Aug 62 daysKhattar Jack A.President, CEOSSale−140.0K$42.02−$5.88M−11.6%1.07M after3 lots10b5-1
Aug 18, 2025 (view filing)Aug 144 daysHudson Frederick M.DirectorSSale−7.46K$42.26−$315.1K−13.9%46.3K after